CEO at Syndax Pharmaceuticals


      Syndax Pharmaceuticals
  


      MPM Capital
  

About us

  AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines.

Our Purpose is to push the boundaries of science to deliver life-changing medicines.  We believe the best way we can achieve our Purpose is to put science at the centre of everything we do. Science defines who we are. It is why we come to work every day and is part of our DNA. But this is only half of the story. We know that we do not have all the answers. We want to share ideas because we believe it results in better medicines.  We want the way we work to be inclusive, open and collaborative.  This approach runs through all that we do.

We focus on three main therapy areas – Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory – and we are also selectively active in the areas of autoimmunity, neuroscience and infection. To put ourselves in the best position to push the boundaries of science, we seek to leverage our combination of capabilities, which encompass both small molecules and biologics, and include immunotherapies and developing innovative delivery devices that can offer choice to patients. These are reinforced by a strong focus on personalised healthcare capabilities, which aim to match medicines only to those patients who will benefit from them. Our teams also work alongside the world's leading academic and biotech research institutions to stimulate innovation and evaluate emerging technologies such as Modified RNA and CRISPR genome editing.

AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, visit www.astrazeneca.com.


      AstraZeneca
  


      PFIZER
  

About us

  Merck is a leading global biopharmaceutical company that has been inventing for life for more than a century, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola. This site is intended for residents of the United States and its territories.  For more information, visit www.merck.com.

Merck

The University of Connecticut Health Center

Georgetown University is the oldest and largest Catholic and Jesuit university in America. Georgetown today is a major student-centered, international research university, offering programs in Washington, DC; Doha, Qatar; and around the world.

CEO at Syndax Pharmaceuticals

Syndax Pharmaceuticals

CEO

MPM Capital

Managing Director

AstraZeneca

Executive Vice President, Global Medicines Development

PFIZER

SVP

Merck

various

Dana Farber Cancer Institute

Medical Oncology

Fellowship

Mass General Hosipital

Internal Medicine

Intern/Resident

The University of Connecticut Health Center

Medicine

MD

Georgetown University

Biology, General

Bachelor of Science (BS)